A step forward in the everyday management of adults with community acquired pneumonia
- 31 January 2005
- Vol. 330 (7489) , 460
- https://doi.org/10.1136/bmj.38378.607130.55
Abstract
Footnotes Conflict of interest MW has received travel expenses and lecture fees from several manufacturers of macrolide and fluoroquinolone antibiotics, including GlaxoSmithKline, Bayer, and Pfizer. TJMV has received travel expenses from GlaxoSmithKline.Keywords
This publication has 4 references indexed in Scilit:
- Effectiveness of β lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysisBMJ, 2005
- Management of Patients with Community-acquired Pneumonia Treated in Hospital in SwedenScandinavian Journal of Infectious Diseases, 2002
- BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.Published by Korean Cancer Association ,2001
- Use of investigations in lower respiratory tract infection in the community: a European surveyEuropean Respiratory Journal, 1996